RxDoctor Payments Data

Peter Koenig Pa-C

Medical · Thornton, CONPI 1326416140

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.8% of the total across 397 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,033 and has fallen 96.5% since, to $71 in 2025. Among medical clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,178in general payments, 2019–2025

Across 397 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$698
  • Boehringer Ingelheim$695
  • Lilly USA, LLC$632
  • Novo Nordisk$525
  • Amgen$391
  • plus $3K from 34 others

What the payments were for

  • Food & beverage$7,167100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,178 in reported general payments places this provider in the 90th percentile of 766 medical providers in Colorado.

See all medical providers in Colorado

Medicare billing

Part B allowed, 2024
$7,354
Medicare patients
34
Services billed
94

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin15$25,656
MounjaroTirzepatide23$24,776
OzempicSemaglutide18$21,771
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr25$13,114
EliquisApixaban20$13,066
LantusInsulin Glargine,hum.Rec.Anlog11$1,363
Omeprazole39$1,168
Atorvastatin Calcium96$742
Gabapentin26$653
Albuterol Sulfate HfaAlbuterol Sulfate19$496
Levothyroxine Sodium49$418
Metformin Hcl ErMetformin Hcl32$409
Rosuvastatin Calcium33$391
Lisinopril47$329
Metoprolol Succinate21$306

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$695$25,65615 claims
Lilly USA, LLCMounjaro$632$24,77623 claims
Novo NordiskOzempic$525$21,77118 claims
GSKAnoro Ellipta$307$13,11425 claims
PfizerEliquis$248$13,06620 claims
Sanofi-aventis U.S. LLCLantus$19$1,36311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 766 medical providers in Colorado.

Other medical in Thornton

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →